Mistakes in acute jaundice and how to avoid them

Filters:

UEG Mistakes In Articles

Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Not sure what you can access? Learn more about account types.

Mistakes in acute jaundice and how to avoid them

Spyridon Siakavellas, Georgios Papatheodoridis

Summary

AI Generated

Jaundice arises from abnormalities in bilirubin formation, metabolism, or excretion, or from biliary tree obstruction at any anatomical level, and numerous conditions can cause it.

Jaundice can result from abnormalities in bilirubin formation, metabolism, and excretion processes
Obstruction of the biliary tree from intrahepatic origins to the ampulla of Vater can cause jaundice even when bilirubin processing is functioning properly
The material presents the view that a careful diagnostic approach is warranted to identify the underlying cause
The material states that prompt intervention saves lives in many cases, contrasting with conventional wisdom that jaundice by itself never killed anyone

Download PDF

Was this helpful?

Thanks for your feedback.

This summary was generated by an AI large language model based on the content transcript. It is for informational purposes only and should not be considered a substitute for clinical judgment. Always rely on your professional expertise and the full clinical context when making clinical decisions.

References

Mistakes

References

Mistake 1 Mistake 2 Mistake 3 Mistake 4 Mistake 5 Mistake 6 Mistake 7 Mistake 8 Mistake 9 Mistake 10

Fevery J. Bilirubin in clinical practice: a review. Liver Int 2008; 28: 592–605. [Link]

Silverberg NB and Lee-Wong M. Generalized yellow discoloration of the skin. The diagnosis: carotenemia. Cutis 2014; 93: E11–E12. [Link]

Erlinger S, Arias IM and Dhumeaux D. Inherited disorders of bilirubin transport and conjugation: new insights into molecular mechanisms and consequences. Gastroenterology 2014; 146: 1625–1638. [Link]

Marchand A, Galen RS and Van Lente F. The predictive value of serum haptoglobin in hemolytic disease. JAMA 1980; 243: 1909–1911. [Link]

Vitek L, et al. Gilbert syndrome and ischemic heart disease: a protective effect of elevated bilirubin levels. Atherosclerosis 2002; 160: 449–456. [Link]

European Association for the Study of the Liver. EASL Clinical Practical Guidelines on the management of acute (fulminant) liver failure. J Hepatol 2017; 66: 1047–1081. [Link]

Taylor T and Wheatley M. Jaundice in the emergency department: meeting the challenges of diagnosis and treatment. Emerg Med Pract 2018; 20: 1–24. [Link]

Vuppalanchi R, Liangpunsakul S and Chalasani N. Etiology of new-onset jaundice: how often is it caused by idiosyncratic drug-induced liver injury in the United States? Am J Gastroenterol 2007; 102: 558–562. [Link]

European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Autoimmune hepatitis. J Hepatol 2015; 63: 971–1004. [Link]

10.

Chand N and Sanyal AJ. Sepsis-induced cholestasis. Hepatology 2007; 45: 230–241. [Link]

11.

Giallourakis CC, Rosenberg PM and Friedman LS. The liver in heart failure. Clinics Liv Dis 2002; 6: 947–967. [Link]

12.

van Lingen R, et al. Jaundice as a presentation of heart failure. J R Soc Med 2005; 98: 357–359. [Link]

13.

Okwara CJ, et al. Jaundice: A thyroid problem? Dig Dis Sci 2017; 62: 1901–1905. [Link]

14.

Saik RP, et al. Spectrum of cholangitis. Am J Surg 1975; 130: 143–150. [Link]

15.

Miura F, et al. TG13 flowchart for the management of acute cholangitis and cholecystitis. J Hepatobiliary Pancreat Sci 2013; 20: 47–54. [Link]

16.

Thursz MR, et al. Prednisolone or pentoxifylline for alcoholic hepatitis. New Engl J Med 2015; 372: 1619–1628. [Link]

17.

Crabb DW, et al. Standard definitions and common data elements for clinical trials in patients with alcoholic hepatitis: Recommendation From the NIAAA Alcoholic Hepatitis Consortia. Gastroenterology 2016; 150: 785–790. [Link]

18.

Moreau R, et al. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology 2013; 144: 1426–1437, e1–9. [Link]

19.

Desmet VJ, et al. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994; 19: 1513–1520. [Link]

20.

Kamath PS, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33: 464–470. [Link]

Abstract

Jaundice can be caused by abnormalities in any of the steps comprising the formation, metabolism and excretion of bilirubin. In addition, these processes may be functioning properly, but jaundice can be seen because of an obstruction of the biliary tree at any point, from its intrahepatic origins to its end at the ampulla of Vater. For this reason, it is clear that numerous conditions can result in jaundice. When faced with a patient presenting with jaundice a reasonable and careful diagnostic approach is, therefore, warranted to elucidate the underlying cause of this sign. Conventional wisdom may be that “jaundice by itself never killed anyone,” but it is imperative to find the cause as soon as possible, as prompt intervention saves lives in many cases.

Topics

Hepatobiliary

Citation

Siakavellas S and Papatheodoridis G. Mistakes in acute jaundice and how to avoid them. UEG Education 2018; 18: 24–26.

Published

2025

More Like This:

From Vienna to Berlin: What inspired us last year at UEG Week

Pradeep Mundre

Episode 6: UEG Journal October Spotlight

Maria Manuela Estevinho

Oesophageal cancer with Massimiliano di Pietro (Part 2)

Pradeep Mundre

Pancreatic cystic neoplasms with Marco del Chiaro

Egle Dieninyte - Misiune

Ian Gralnek on UEG Week 2024

Egle Dieninyte - Misiune

ECCO-ESGAR-ESP-IBUS Guideline on Diagnostics and Monitoring of Patients with Inflammatory Bowel Disease: Part 1: initial diagnosis, monitoring of known inflammatory bowel disease, detection of complications

Torsten Kucharzik

UEG Podcast Episode

UEG Podcast

Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Not sure what you can access? Learn more about account types.

From Vienna to Berlin: What inspired us last year at UEG Week

Egle Dieninyte - Misiune, Pradeep Mundre

Summary

AI Generated

Summary is not available for this content yet.

Download PDF

Was this helpful?

Thanks for your feedback.

Abstract

Published

2025

More Like This:

From Vienna to Berlin: What inspired us last year at UEG Week

Pradeep Mundre

Episode 6: UEG Journal October Spotlight

Maria Manuela Estevinho

Oesophageal cancer with Massimiliano di Pietro (Part 2)

Pradeep Mundre

Pancreatic cystic neoplasms with Marco del Chiaro

Egle Dieninyte - Misiune

Ian Gralnek on UEG Week 2024

Egle Dieninyte - Misiune

ECCO-ESGAR-ESP-IBUS Guideline on Diagnostics and Monitoring of Patients with Inflammatory Bowel Disease: Part 1: initial diagnosis, monitoring of known inflammatory bowel disease, detection of complications

Torsten Kucharzik

UEG Podcast Episode

Journal Podcast

Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Not sure what you can access? Learn more about account types.

Episode 6: UEG Journal October Spotlight

Mohsan Subhani, Maria Manuela Estevinho

Summary

AI Generated

Summary is not available for this content yet.

Download PDF

Was this helpful?

Thanks for your feedback.

Abstract

Topics

Endoscopy Hepatobiliary IBD Pancreas

Published

2025

More Like This:

From Vienna to Berlin: What inspired us last year at UEG Week

Pradeep Mundre

Episode 6: UEG Journal October Spotlight

Maria Manuela Estevinho

Oesophageal cancer with Massimiliano di Pietro (Part 2)

Pradeep Mundre

Pancreatic cystic neoplasms with Marco del Chiaro

Egle Dieninyte - Misiune

Ian Gralnek on UEG Week 2024

Egle Dieninyte - Misiune

ECCO-ESGAR-ESP-IBUS Guideline on Diagnostics and Monitoring of Patients with Inflammatory Bowel Disease: Part 1: initial diagnosis, monitoring of known inflammatory bowel disease, detection of complications

Torsten Kucharzik

UEG Podcast Episode

UEG Podcast

Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Not sure what you can access? Learn more about account types.

Oesophageal cancer with Massimiliano di Pietro (Part 2)

Massimiliano di Pietro, Pradeep Mundre

Summary

AI Generated

Summary is not available for this content yet.

Download PDF

Was this helpful?

Thanks for your feedback.

Abstract

Topics

Digestive Oncology Endoscopy Oesophagus

Published

2025

More Like This:

From Vienna to Berlin: What inspired us last year at UEG Week

Pradeep Mundre

Episode 6: UEG Journal October Spotlight

Maria Manuela Estevinho

Oesophageal cancer with Massimiliano di Pietro (Part 2)

Pradeep Mundre

Pancreatic cystic neoplasms with Marco del Chiaro

Egle Dieninyte - Misiune

Ian Gralnek on UEG Week 2024

Egle Dieninyte - Misiune

ECCO-ESGAR-ESP-IBUS Guideline on Diagnostics and Monitoring of Patients with Inflammatory Bowel Disease: Part 1: initial diagnosis, monitoring of known inflammatory bowel disease, detection of complications

Torsten Kucharzik

UEG Podcast Episode

UEG Podcast

Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Not sure what you can access? Learn more about account types.

Pancreatic cystic neoplasms with Marco del Chiaro

Marco Del Chiaro, Egle Dieninyte - Misiune

Summary

AI Generated

Summary is not available for this content yet.

Download PDF

Was this helpful?

Thanks for your feedback.

Abstract

Topics

Pancreas

Published

2025

More Like This:

From Vienna to Berlin: What inspired us last year at UEG Week

Pradeep Mundre

Episode 6: UEG Journal October Spotlight

Maria Manuela Estevinho

Oesophageal cancer with Massimiliano di Pietro (Part 2)

Pradeep Mundre

Pancreatic cystic neoplasms with Marco del Chiaro

Egle Dieninyte - Misiune

Ian Gralnek on UEG Week 2024

Egle Dieninyte - Misiune

ECCO-ESGAR-ESP-IBUS Guideline on Diagnostics and Monitoring of Patients with Inflammatory Bowel Disease: Part 1: initial diagnosis, monitoring of known inflammatory bowel disease, detection of complications

Torsten Kucharzik

UEG Podcast Episode

UEG Podcast

Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Not sure what you can access? Learn more about account types.

Ian Gralnek on UEG Week 2024

Ian Mark Gralnek, Egle Dieninyte - Misiune

Summary

AI Generated

Summary is not available for this content yet.

Download PDF

Was this helpful?

Thanks for your feedback.

Abstract

Topics

Endoscopy

Published

2025

More Like This:

From Vienna to Berlin: What inspired us last year at UEG Week

Pradeep Mundre

Episode 6: UEG Journal October Spotlight

Maria Manuela Estevinho

Oesophageal cancer with Massimiliano di Pietro (Part 2)

Pradeep Mundre

Pancreatic cystic neoplasms with Marco del Chiaro

Egle Dieninyte - Misiune

Ian Gralnek on UEG Week 2024

Egle Dieninyte - Misiune

ECCO-ESGAR-ESP-IBUS Guideline on Diagnostics and Monitoring of Patients with Inflammatory Bowel Disease: Part 1: initial diagnosis, monitoring of known inflammatory bowel disease, detection of complications

Torsten Kucharzik

UEG Standards and Guidelines

Clinical Practice Guideline

Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Not sure what you can access? Learn more about account types.

ECCO-ESGAR-ESP-IBUS Guideline on Diagnostics and Monitoring of Patients with Inflammatory Bowel Disease: Part 1: initial diagnosis, monitoring of known inflammatory bowel disease, detection of complications

Torsten Kucharzik

Summary

AI Generated

Summary is not available for this content yet.

Download PDF

Was this helpful?

Thanks for your feedback.

Guideline

Abstract

The current consensus guideline offers a comprehensive and practical guidance on the diagnostic and monitoring of patients with inflammatory bowel disease (IBD). It provides recommendations on requirements for initial diagnosis, detection of complications, the use of monitoring tools in patients with IBD and diagnostics in specific situations, such as pregnancy, postoperatively and for cancer surveillance. The guideline is a joint project of the European Crohn’s and Colitis Organization (ECCO), the European Society of Gastrointestinal and Abdominal Radiology, the European Society of Pathology, and the International Bowel Ultrasonography Group under the leadership of ECCO.

Publisher

European Crohn’s and Colitis Organisation

Guideline

Clinical Practice Guideline

Topics

IBD

Citation

Journal of Crohn's and Colitis, Volume 19, Issue 7

Published

2025

More Like This:

From Vienna to Berlin: What inspired us last year at UEG Week

Pradeep Mundre

Episode 6: UEG Journal October Spotlight

Maria Manuela Estevinho

Oesophageal cancer with Massimiliano di Pietro (Part 2)

Pradeep Mundre

Pancreatic cystic neoplasms with Marco del Chiaro

Egle Dieninyte - Misiune

Ian Gralnek on UEG Week 2024

Egle Dieninyte - Misiune

ECCO-ESGAR-ESP-IBUS Guideline on Diagnostics and Monitoring of Patients with Inflammatory Bowel Disease: Part 1: initial diagnosis, monitoring of known inflammatory bowel disease, detection of complications

Torsten Kucharzik